Bharat Biotech’s Covaxin Shows 78 Percent Efficacy In Phase 3 Analysis

Bharat Biotech’s Covaxin Shows 78 Percent Efficacy In Phase 3 Analysis
Photo courtesy: Swarajyamag

The final phase 3 analysis of Covaxin, the Covid-19 jab developed by Bharat Biotech, has shown the efficacy of 78 per cent in preventing symptomatic coronavirus caused disease, a report said.

.

Read more at: https://swarajyamag.com/news-brief/bharat-biotechs-covaxin-shows-78-percent-efficacy-in-phase-3-analysis

.

Visit www.werindia.com OR Hindi.werindia.com to read news from 500+ news sources... आपका अपना डिजिटल अख़बार |



     
  • 31 May 2021
  • WerIndia

Leave a Reply


Recommended for you

Your Opinion

For the 2024 Lok Sabha election, of the nearly 100 Crores Voters, what you expect to be the total Voting Percentage:

View Results

Loading ... Loading ...

View Older Polls

आपकी राय

2024 के लोकसभा चुनाव के लिए, लगभग 100 करोड़ मतदाताओं में से, आपको क्या उम्मीद है कि कुल मतदान कितने प्रतिशत होगा?

View Results

Loading ... Loading ...

View Older Polls